DARIFENACIN
Active substance: darifenacin
TABLET, EXTENDED RELEASE · DARIFENACIN HYDROBROMIDE 15 mg/1
United StatesActive
Marketing holder: Alembic Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DARIFENACIN HYDROBROMIDE · 15 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-c6a4-7252-95d5-ce4ed984c017,01a1208e-c4c8-70f8-9f03-820014185c2c,01a1208f-920f-7d89-bae0-0a24331279e3,01a12094-4093-78c3-ae12-5be998716c76,01a12097-39ab-7c1e-adcc-159d81b024e3;count=16 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62332-224
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 62332-224 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62332-224 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62332-224 · Verified 2026-10-09 · open in source